BACK TO NEWS ROOM


U.T. System Partners with the State of Texas to Expand Opportunities to Texans

From breakthrough cancer imaging and drug delivery systems to alternative energies and freight tracking technology, new discoveries that result from the vast research and development activities at the fifteen U. T. System universities are helping to accelerate opportunities for Texans and changing lives around the globe.  The ETF’s financial support is boosting the U. T. System’s resources to expand and accelerate the commercialization of these activities.

  • Nearly $33 million in total ETF commercialization awards has been approved for 31 companies with collaborative activities from ten U. T. System institutions. Here are a few company snapshots:
    • The ETF great success story of CardioSpectra started with a fiber-optic cardiac catheter developed in a collaboration between U. T. Austin and U. T. Health Science Center at San Antonio (UTHSC-SA).
    • Molecular Imprintsis “building the tools that build the nano-world®” with Step and Flash® imprint lithography (S-FIL®) developed at U. T. Austin for semiconductor device and other industry manufacturers.
    • Endothelix, Inc.’smonitoring technology for cardiovascular health, developed at U. T. Health Science Center at Houston (UTHSC-H), incorporates non-invasive, non-imaging vascular function monitoring technologies in risk factor assessments to help doctors more accurately monitor patients’ cardiovascular health and choose therapies to prevent and treat heart attacks and strokes.
    • PLx Pharma, Inc. is a pharmaceutical company developing the next generation of safer non-steroidal anti-inflammatory agents (NSAIDs). IP was developed in collaboration among UTHSC-H, U. T. Medical Branch at Galveston (UTMB), and MD Anderson Cancer Center (UTMDACC). Phase III Clinical Trials are completed for several drugs, and preclinical trials are underway for other medications used for pain, inflammation, and cardiovascular treatment.
    • NanoSpectra Biosciences, Inc.is commercializing AuroLase™ Therapy, a breakthrough “Smart Drug” delivery system, the IP for which was developed at UTMDACC, UTMB, Texas A&M, and Rice. The company plans to start clinical trials with head and neck cancer patients in 2008 using AuroLase™ Therapy to selectively and precisely destroy solid tumors while minimizing damage to healthy adjacent tissue and preserving critical structures. 
  • Five ETF Research Superiority Acquisition of Talent awards totaling more than $23 million and involving six U. T. System institutions have been approved, and approximately $10 million has been funded ($5 million in December ‘07 and January ‘08). Already these awards boast results as follows:
  • Two New Companies formed with licensed IP (Leonardo Biosystems and Nanomedical Systems)
  • 10 New Patents filed (4 international) and 15 New Technology invention disclosures
  • 48 New Hires, with 100 Employees conducting or supporting the research
  • $15M non state-of-Texas grants and other funds (Excludes U. T. System and other matching funds and multi-million dollar DARPA grants.)
  • Nanoelectronics Initiative created to recruit world class experts at three U. T. universities (U. T. Austin, U. T. Dallas, and U. T. Arlington); to establish collaborative research among them; and to jointly develop and commercialize their discoveries. Four experts have been hired to date.

 

  • ETF Research Matching funds totaling $21.5 million have been awarded to three U. T. System institutions for five nanotech, semiconductor, and IT projects.

Companies with U. T. System affiliations and commercialization commitments from the ETF:

Company

Industry

Technology

University(ies)

Lasertissue Welding

Life Science

Surgical Therapy

UTMDACC

SNRLabs Corp

IT

Handset Software - conver mgr

UT Dallas

Visualase, Inc.

LS/IT

MRI Guided Laser

UTMDACC

Net Watch Solutions

IT

IT Mgmt Software

UT Dallas

Micro Transponder

Life Science

Neurostimulation Med Device

UT Dallas, UTMDA

Xitonic Corp

Semiconductor

Photo-Reflective Tech

UT Austin

Texas Piezoelectric

Energy

Energy Harvesting Device

UT Arlington

Ortho-Accel

Life Science

Orthodontia Tech

HSC Houston

DNAtriX, Inc.

Life Science

Cancer Therapy

UTMDACC

Halsa Pharma

Life Science

Clinical Obesity-Drug Dev

UT Austin

TXL Group

Energy

Thermoelectric Gen Tech

UT El Paso

Falcon Inter, Inc.

Def/Aerospace

Ballistic Panel Tech

UT Permian Basin

Bauhaus Inc.

Software

Application Software

UTSA

CardioSpectra

Life Science

Fiber-optic Cardiac Catheter

UT Austin, UTHSC-SA

Endothelix

Life Science

Cardiovascular Test

UTHSCH

Hanson Robotics

Robotics

Animatronics

UTA, UTD

Molecular Imprints

Semiconductor

Imprint Lithography

UT Austin

Molecular LogiX

Life Science

Pan-Her Anticancer Ligands

UTMDACC, UTHSC-SA

Monebo (monebo.com)

Life Science

Heart Health Assessment

UT Austin

Nanocoolers, Inc.

Semiconductor

Nano cooling System

UT Austin

NanoSpectra

Life Science

Oncologic Imaging Detection

UTMDACC, UTMB, A&M, Rice

Optisense

Energy

Electro-Optic HV Sensor

UT Arlington

Photodigm

IT

Semiconductor Lasers

UT Dallas

PLx Pharma, Inc.

Life Science

Drug Delivery Device - NAISD's

UTHSC-H, UTMB, UTMDACC

PrincleSoft

IT

Multiple-Layer Overlay

UT Dallas

Quantum Logic

Life Science

Med Platforms

UT Austin

Resonant Sensors

Life Science

Optical BioChem Sensors

UT Arlington, UT SwMed

Secure Origins

IT

Freight tracking technology

UT El Paso, Cal Poly

Seno Medical

Life Science

Laser Optical-Cancer Imaging

UTHSC-SA, UTMB Gal

Xilas Medical

Life Science

Foot-related diabetic products

UTHSC-SA

Xtreme Power

Energy

Power Load Leveling

UT Austin

 

BACK TO NEWS ROOM



 



HOME | LEARN MORE | EVENTS | SUCCESSES | NEWS ROOM | PARTNERS | E-NEWSLETTER | CONTACT
Copyright © 2008 Texas Coalition for Capital. Designed by presleydesignstudio.com. All Rights Reserved.